Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.

JCO clinical cancer informatics - 1 May 2024

Nepomuceno Thales C, Lyra Paulo, Zhu Jianbin, Yi Fanchao, Martin Rachael H, Lupu Daniel, Peterson Luke, Peres Lauren C, Berry Anna, Iversen Edwin S, Couch Fergus J, Mo Qianxing, Monteiro Alvaro N

Abstract excerpt

PURPOSE: The emergence of large real-world clinical databases and tools to mine electronic medical records has allowed for an unprecedented look at large data sets with clinical and epidemiologic correlates. In clinical cancer genetics, real-world databases allow for the investigation of prevalence and effectiveness of prevention strategies and targeted treatments and for the identification of barriers to better...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Electronic Health Records

Share to Genetic Predisposition to Disease

Share to Germ-Line Mutation

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 38709234
DOI: 10.1200/CCI.23.00251
PMCID: PMC11161245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.PMID 38709234Read ↗

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.Semantic proximity Read ↗

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.Semantic proximity Read ↗

Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationSemantic proximity Read ↗

Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.Semantic proximity Read ↗

Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.Semantic proximity Read ↗

Exome Sequencing Reveals a High Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Founder Variants in a Diverse Population-Based BiobankSemantic proximity Read ↗

Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.Semantic proximity Read ↗

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.Semantic proximity Read ↗

A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.Semantic proximity Read ↗

A new bioinformatics tool to help assess the significance of BRCA1 variants.Semantic proximity Read ↗

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.Semantic proximity Read ↗

Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.